TOXIC FREE PHILLY
  • Home
  • Why Toxic Free?
  • What you can do
  • Organic Lands
  • Updates
  • Contact
  • HOPS Documents
  • Home
  • Why Toxic Free?
  • What you can do
  • Organic Lands
  • Updates
  • Contact
  • HOPS Documents

Monsanto Hit With $78M Verdict In Philly's 6th Roundup Trial

10/17/2024

0 Comments

 
By P.J. D'Annunzio
copied from www.law360.com
Law360 (October 10, 2024, 4:03 PM EDT) -- Bayer AG unit Monsanto was hit with a $78 million
verdict on Thursday by a Philadelphia jury in the sixth trial in the city's Roundup weedkiller mass tort.
The jury handed up its verdict — $3 million in compensatory damages and $75 million in punitive
damages — in Philadelphia Court of Common Pleas Judge Craig Levin's courtroom after nearly a
month of trial and two and a half hours of deliberation, finding that the company's flagship herbicide
was defective and the cause of plaintiff William Melissen's cancer.

Melissen alleged he developed non-Hodgkin lymphoma/hairy cell leukemia from using Roundup from
1992 to 2020 in his home and for commercial purposes. Like the plaintiffs in the Roundup cases,
Melissen alleged that Roundup's key ingredient, glyphosate, caused his cancer.

Monsanto has argued that the science shows glyphosate is safe for human use.
During closing arguments prior to the verdict, Melissen's attorneys urged the jury to hold the
"multibillion-dollar mega corporation" Monsanto accountable not just for causing their client's cancer,
but also poisoning "the birds, the butterflies and the environment" in the 50 years that Roundup has
been on the market.

Jason Itkin, an attorney for Melissen, told the jurors they wielded a rare power in this case.
"For the rest of your lives, you may never have the opportunity and power to do so much good," Itkin
said. "There's a catch–the opportunity is only good if you use it. Whether it's five days or five years
from now, you don't want to read something on the news, see a product on the shelf, see someone
go to the hospital and say, 'did I do enough?'"

Monsanto knew that it was selling cancer-causing "poison" the whole time, Itkin said, and never
bothered to warn people to wear gloves or protective gear, let alone pull the weedkiller from the
market.

"It is okay for companies to make a profit, but you cannot put profit over the health of real people
with real families," Itkin said.

Monsanto has the power to influence politicians, scientists, and the media, Itkin said, telling the jury
that only they had the power to stop the corporation.

"You gotta have the courage to award a big enough verdict to deter Monsanto from continuing on its
course of selling poison to people," he said.

Both sides in the litigation accused each other of cherry-picking science to advance their cases, using
experts paid to support their positions, pointing to scientific studies and journal articles with
favorable conclusions, and taking evidence out of context.

Bart Williams, who gave closing arguments on behalf of Monsanto, reiterated the point to the jury
and told them that the plaintiffs' attorneys were trying to solicit an emotional response from them in
order to find against Monsanto.

True it was tragic that Melissen developed cancer, and people naturally have sympathy when
someone is suffering, but the jury had to look at the facts dispassionately, Williams said.
And the facts, he said, all pointed to Roundup being perfectly safe.

Williams urged the jury to utilize their "intellect, analysis, reason, discipline, and common sense" in
answering one question: does Roundup cause cancer? If the answer was no, then the plaintiff's case
falls apart, he said.

"Science is real," he said. "Science leads to the truth. Sometimes that can be unexciting, especially
when you have to sit here and listen to it as jurors, but this case is all about science.
The case is William Melissen et al. v. Monsanto et al., case no. 210602578, in the Philadelphia Court
of Common Pleas.
0 Comments

Drexel University is phasing out herbicides, pesticides on campus grounds

6/3/2024

0 Comments

 
Picture
https://whyy.org/articles/drexel-university-phasing-out-herbicides-pesticides-campus/
Weed killers prevent unwanted plants like crabgrass and dandelions from invading lawns.
However, the chemicals found in such products can impact the environment if stormwater runoff carries them to local waterways. Research has found exposure to herbicides and pesticides may cause serious illnesses, including some cancers, among humans and animals.
So, Drexel University’s groundskeepers will replace the synthetic chemicals campus-wide, with an organic turf program that includes organic fertilizer, overseeding and aeration. The decision comes after a group of students voiced concern about the use of weed killers.
The decision was made following the success of a grant-funded pilot program using safer alternatives at the university’s Drexel Park.
“With synthetic pesticides, fertilizers, and especially synthetic herbicides, there are risks that are just not entirely necessary, especially when there is such a great alternative available, which is organic turf care,” said Kacy Gao, a third-year student who helped advocate for the change. “I would hope that residents… just enjoy this space recreationally, knowing that it is not treated with synthetic herbicides.”
The students partnered with environmental groups Toxic Free Philly and Re:wild Your Campus, which have been calling for institutions and governments to reduce pesticide and herbicide use.
About 16 tons of toxic herbicides were sprayed in Philadelphia in 2022 alone, according to Toxic Free Philly. Researchers say every person in the U.S. has some level of pesticides in their blood or urine. 
Herbicides also are disproportionately sprayed in communities of color and low-income neighborhoods, according to The Black Institute.
Though the data is limited, some studies suggest herbicides such as Roundup are associated with non-Hodgkin’s lymphoma and some other cancers, said Anneclaire De Roos, a professor at Drexel’s Dornsife School of Public Health. That has led to numerous lawsuits against the companies that manufacture the products, such as Monsanto.De Roos added that in addition to potentially contaminating waterways, herbicides can impact wildlife and the environment by reducing biodiversity and ecosystem functions.
“[Using herbicide is] purely cosmetic on some place like a university campus. So the students, with their concern for the environment and health, and also for biodiversity and wildlife, that was the reason that they pushed for [an alternative],” she said. “The health concerns are there, and these are possible and probable carcinogens. But even beyond that, a push for this was ecological as well.”

Landscapers say organic fertilizer doesn’t directly eliminate weeds, but it helps improve turf health. The healthier the grass, the more likely it can keep weeds out.
Drexel’s groundskeepers say they’ve struggled to maintain grass coverage at Drexel Park, because it’s a popular spot for people to walk their dogs or play football with friends.
The reduced grass has allowed unwanted weeds to take over the park, said Tony Gale, Drexel’s assistant director for grounds. Since using organic fertilizer at the park, grass health has improved, he said.
Gale said he feels more comfortable using the safer alternative in such a populated area.
“We used to [use herbicides] early on Saturday mornings, and it was very quiet around here. But still, you get the early jogger, an early dog walker. There’s always people out,” he said. “So, I’m just as happy to avoid that and not have anyone get sick or have anyone’s pet injured.”

0 Comments

Philadelphia jury awards $2.25 billion to man who claimed Roundup weed killer gave him cancer

1/31/2024

0 Comments

 
  • by Nick Vadala
    Published Jan. 29, 2024, 6:23 p.m. ET by the Philadelphia Inquirer
A Philadelphia jury has delivered a $2.25 billion verdict against agricultural giant Monsanto, deciding in favor of a Pennsylvania man who contended he developed cancer as a result of using the company’s weed killer, Roundup.
The unanimous verdict issued Friday awarded John McKivison, 49, of Lycoming County, $250 million in compensatory damages, and $2 billion in punitive damages. The jury found that Roundup causes cancer, and that Monsanto was negligent and failed to warn consumers of the dangers of the product, said McKivison’s attorneys, Tom Kline of Kline & Specter in Philadelphia, and Jason Itkin of Houston-based Arnold & Itkin.
“We are thankful that this unanimous jury found that Bayer/Monsanto’s Roundup was responsible for causing John McKivison’s blood cancer,” Kline and Itkin said in a statement. “The jury’s punitive damages award sends a clear message that this multi-national corporation needs top to bottom change.”
McKivison’s attorneys said that he began using Roundup at his job at a warehouse when he was in his 20s. Because the product killed weeds effectively at his work, McKivison began spraying it regularly at his family’s home over the next two decades, his attorneys said. McKivison’s personal properties were as large as two acres, and he used the weed killer on food plots he and his family planted to attract wildlife. At one point, his attorneys said, he dispersed Roundup on his property from a tractor in 25- to 30-gallon loads.
“The difference in his life, truly, is that he was exposed to Roundup,” Kline said.
At issue in the case was the chemical glyphosate, Roundup’s active ingredient, as well as other ingredients in the weed killer. Monsanto developed glyphosate in 1974, and it has since become one of the most widely used herbicides worldwide, despite concerns that the chemical is carcinogenic. The lawsuit also named Nouryon, a Radnor-based chemical company that manufacturers another ingredient in Roundup known as a “surfactant” that helps the herbicide effectively kill weeds.
World agencies have differed on glyphosate’s carcinogenic properties.
In 2015, the International Agency for Research on Cancer, part of the World Health Organization, classified glyphosate as part of a group of chemicals that are “probably carcinogenic to humans.”
0 Comments

Monsanto's legal liabilities are pushing Bayer to the Brink: DW news report

12/27/2023

0 Comments

 
It’s one of Europe’s major industrial players, but Bayer continues to struggle. It’s takeover of controversial seed- and chemicals-giant Monsanto in 2018 saddled it with billions in legal fees and payments from the pesticide known as "Roundup." New court judgments added to its woes this year – Bayer stock is down 30 percent from the beginning of 2023. Investors are growing restless. ​
Picture
0 Comments

"Into the Weeds" Roundup documentary now available to stream

12/27/2023

0 Comments

 
Into the Weeds is a Canadian documentary film, directed by Jennifer Baichwal and released in 2022. The film centres on Dewayne "Lee" Johnson, the California man whose health problems after longterm exposure to glyphosate in the herbicide product Roundup led to the landmark Johnson v. Monsanto Co. court case, which proved, using Monsanto's own internal documents obtained during discovery, that Monsanto knew of RoundUp's carcinogenic effects.

​Rent or buy Into the Weeds on Amazon
Stream Into the Weeds on Apple TV+
0 Comments

Philadelphia Jury Awards $3.5 Million in Roundup Lawsuit Against Bayer

12/27/2023

0 Comments

 
Source: https://www.legalexaminer.com/environment/roundup-lawsuits/another-win-for-roundup-lawsuit-plaintiffs/
A Philadelphia court ruling earlier this month marks the fifth consecutive trial loss for pharmaceutical giant Bayer, whose Roundup weedkiller was named responsible for a Pennsylvania woman’s non-Hodgkin lymphoma.
Plaintiff Kelly Martel was awarded nearly $3.5 million in damages, a much smaller amount than other recent Bayer losses. In November, just three plaintiffs won $1.56 billion.
​


Although amounts that high could be reduced because they exceed U.S. Supreme Court guidance, the verdicts represent a significant turn of fortune for Roundup users, hundreds of thousands of whom have sued Bayer for exposure to glyphosate, the weedkiller’s main ingredient. They say the herbicide gave them cancer, most notably non-Hodgkin lymphoma. 
Bayer won nine cases before their streak was broken in October with three losses in three states totaling more than $500 million. 
Martel’s lawsuit was actually against Nouryon Chemicals, its various subsidiaries, and Monsanto, not Bayer itself. Her lawyers contended that Nouryon created a chemical compound that enhanced Roundup’s cancer-causing properties.
In a 10-2 split, the jury found Monsanto 92.5 percent liable for her injuries and Nouryon just 7.5 percent.
“We disagree with the jury’s divided verdict and the modest damages award that conflicts with the overwhelming weight of scientific evidence and worldwide regulatory and scientific assessments, and believe that we have strong arguments on appeal to get this verdict overturned,” said Chris Loder, Bayer’s Head of External Relations.
The Environmental Protection Agency (EPA) maintains that glyphosate is safe when used correctly, and in November, the European Union renewed its use for another ten years.
The World Health Organization (WHO) classified glyphosate as a probable carcinogen in 2015. Although they were later found to have edited out evidence contradicting those results, independent research has reached similar conclusions. One 2019 study suggested that glyphosate exposure increases cancer risk by 41 percent. 
A new scientific paper published earlier this month found that pregnant women living near farm fields show “significantly” increased amounts of glyphosate in their urine while farmers are spraying the fields. The participants did not work with glyphosate; they only lived near farms that used it.
These findings echo other recent research showing that gestational exposure to glyphosate is associated with reduced fetal growth and other in-utero problems.
Bayer acquired Roundup in 2018 after purchasing Monsanto for $63 billion, to the vehement protest of some shareholders.
Those shareholders are now putting pressure on Bayer to end the litigation, which company officials hoped might be possible during their nine-case winning streak. 
Bayer is currently facing about 50,000 Roundup lawsuits, even after agreeing in 2020 to pay nearly $10 billion to settle nearly 125,000 then-existing claims.
Roundup lawsuits allege that the ingredients in the herbicide are harmful to human health and that Monsanto and Bayer either knew of these dangers and kept that knowledge from consumers or performed inadequate safety tests before releasing the product.
A change in plaintiffs’ strategy could explain the shift in victories, as recent judges have allowed jurors to hear testimony not utilized in previous trials that Bayer calls improper evidence.
“Plaintiffs are on a winning streak,” Nora Freeman Engstrom, a Stanford Law professor who studies mass tort actions, told the New York Times. She said the recent verdicts don’t bode well for Bayer because plaintiffs’ lawyers can use statements from prior testimony to build a stronger case over time.
“With each trial, the playing field shifts subtly toward plaintiffs.”
For example, jurors learned of a federal appeals court’s 2022 ruling that the EPA must reconsider its 2020 decision on glyphosate’s safety. Plaintiffs’ lawyers, as in Martel’s case, have also been focusing more on the theory that other ingredients in Roundup (e.g., known toxins like arsenic and formaldehyde) increase its carcinogenic potential.
At least a dozen more Roundup trials are expected in 2024; Bayer has attempted to placate shareholders by pledging another $6.5 billion in reserved funds to settle those cases. 
But since the merger of Bayer and Monsanto was announced – even before Roundup litigation began – Bayer’s shares have fallen more than 60 percent. The company’s market capitalization is now worth approximately $33 billion, less than half of what it paid for Monsanto.
Roundup has been the world’s most popular herbicide since Monsanto began selling it in 1974.
Bayer has maintained that Roundup is safe and says it will continue to fight recent verdicts. The company has unsuccessfully attempted to end Roundup litigation via a Supreme Court ruling and Congressional bill.
Bayer stopped selling Roundup for residential use in January 2023; it remains available for commercial and agricultural use.
Roundup users who have developed cancer and believe it may be due to glyphosate exposure should contact an experienced Roundup lawyer to assess their eligibility for a claim.

0 Comments

Assessment of the 2022 PPR Pesticide Report

12/27/2023

0 Comments

 
 Glyphosate and 2,4-D Herbicide Use in Philadelphia Outdoor Spaces in 2022 by PPR
A provision in the HOPS bill requires Philadelphia Parks and Rec and all other government divisions that apply pesticides to public spaces to start keeping records of pesticide applications, which they were not doing previously to the passage of HOPS.  TFP put in a right to know request for 2022's pesticide report, which was not made public. The request was granted and below is TFP's first analysis of the 10 page report.

The total amount of glyphosate herbicide used: Approximately 61,000 fluid ounces or 3800 lbs
- Contractors sprayed roughly 47,200 fluid ounces or 2925 lbs
- PPR staff sprayed roughly 14,000 fluid ounces or 875 lbs.
- The stated use of the large majority of glyphosate by PPR staff was for Ballfields, Building Perimeter Fence Lines, Trail and Forest Edges, Pavement Sidewalks, and Right of Way areas.
- The stated use of glyphosate by Contractors was for Forest Restoration and Meadows.

The total amount of 2,4-D herbicide used: 192,000 fluid ounces or 12,000 lbs.
- The stated use of 2,4-D herbicide in 4 large applications by PPR staff was for Pavement.

What are the Health Dangers Associated with Glyphosate in Our Food and Water?
There is no established safe level of glyphosate. Independent studies have linked glyphosate to non-Hodgkin’s lymphoma, early deaths from Parkinson’s, liver and kidney disease and neurotoxicity.
 
Industry tests on glyphosate reveal toxic effects, notably birth defects below the levels that regulators claimed showed no toxic effects.

There is strong evidence that glyphosate can cause damage directly to DNA.
 
Glyphosate has been shown to be a hormone disruptor. Hormone disruption in humans is thought to contribute to some cancers, birth defects, infertility, and developmental problems in fetuses, babies, and children.

Exposure to pesticides adversely affects gut microbiome. A healthy microbiome is needed to develop a baby’s immune system which is needed to prevent cancers.
According to a University of Washington study Roundup increases the risk of some cancers by more than 40%.

Lawsuits
Roundup has been indicted as a carcinogen in several prominent court cases.
On 10/27/2023 a Philadelphia jury awarded $175 million after deciding an 83-year-old man
got cancer from Roundup weed killer

What does science say about the health risks of 2,4-D?
The International Agency for Research on Cancer declared 2,4-D a possible human carcinogen, based on evidence that it damages human cells and, in a number of studies caused cancer in laboratory animals. 2,4-D was one of two active ingredients in the “Agent Orange” herbicide formulation used during the Vietnam War. The U.S Veterans Administration has determined 17 presumptive diseases that may be associated with Agent Orange and are eligible for compensation and treatment. These include: Non-Hodgkin’s Lymphoma, Multiple Myeloma, Parkinson’s Disease, Prostate Cancer, Thyroid Disease, Respiratory Cancers, and Peripheral Neuropathy to name some of the diseases on the list.

​Additionally it is associated with asthma, poor semen quality, birth defects and breast cancer.
There is no established safe level of 2,4-D

Children are uniquely vulnerable to the health effects of pesticide exposure.
The Center for Disease Control and Prevention has found that children age 6-11 have higher levels of common pesticides in their bodies than adults . Many pesticides still widely used in the USA, at the level of tens to hundreds of millions of pounds annually, have been banned or are being phased out in the EU, China and Brazil.
0 Comments

Court Orders EPA to Reassess Whether Glyphosate in Roundup Causes Cancer

6/22/2022

1 Comment

 

EPA failed to follow both the law and its own guidelines in determining whether glyphosate, the active ingredient in Roundup causes cancer, according to opinion.
A federal appeals court has directed the U.S. Environmental Protection Agency (EPA) to re-evaluate the safety of glyphosate, the active ingredient in the controversial weed killer Roundup, which many say is linked to an increased risk of cancer, including non-Hodgkin’s lymphoma. The U.S. Court of Appeals for the Ninth Circuit issued a ruling (PDF) on June 17, that found the EPA used “flawed” reasoning to determine that glyphosate is “unlikely” to cause cancer, and did not follow its own guidelines for making such a determination. The decision stems from a lawsuit (PDF) filed by the National Resources Defense Council (NRDC) and other environmental groups in March 2020, which claimed the EPA did not adequately review the safety or environmental impacts of the ubiquitous herbicide before agreeing to re-approve use of the weed killer. The prior EPA glyphosate safety review faced sharp criticism, as it seemed to ignore warnings issued by the World Health Organization’s International Agency for Research on Cancer (IARC), which decided to classify glyphosate as a probable cancer-causing agent in 2015. The Ninth Circuit ruling comes as Bayer and its Monsanto subsidiary continue to face thousands of Roundup lawsuits brought by former users of the weed killer who developed non-Hodgkin’s lymphoma and other cancer. Although the companies have maintained for years that glyphosate does not cause cancer, billions in Roundup settlements have been paid by the manufacturers to resolve claims.
In a 54-page opinion issued late last week, Judge Michelle Friedland indicated that the EPA failed to follow its own guidelines in determining whether glyphosate in Roundup presents a cancer risk. The agency also failed to follow guidelines laid out in the Federal Insecticide, Fungicide, and Rodenticide Act, as well as its own analysis, Judge Friedland wrote. While the judges also determined EPA failed to follow the Endangered Species Act, the appellate court decided not to provide any relief to plaintiffs on that claim, and also determined the EPA’s ecological review of glyphosate was not flawed, as plaintiffs had claimed. “According to EPA’s conclusion in the Cancer Paper, glyphosate is ‘not likely’ to be carcinogenic to humans because animal-tumor and genotoxicity studies showed no reason for concern,” Judge Friedland wrote. “But this conclusion is in tension with parts of the agency’s own analysis and with the guidelines it purports to follow.” Bayer has maintained the weed killer is safe, and is awaiting a decision by the U.S. Supreme Court about whether it will review a Roundup bellwether trial that resulted in a $25 million verdict for a many who was diagnosed with non-Hodgkin’s lymphoma following Roundup exposure. The case was the first Roundup trial to go before a jury in the federal court system, ending with an $80 million verdict in March 2019. The jury awarded $5 million in compensatory damages for medical bills, lost wages, pain and suffering, with another $75 million added for punitive damages, which were intended to punish Bayer’s Monsanto subsidiary. Following post-trial motions, the punitive damages portion of the award was reduced to $20 million, resulting in a final judgment of $25 million. Bayer has suggested that a successful appeal of that verdict may also prevent other plaintiffs from pursuing their claims. However, the arguments in that appeal are largely based the prior EPA decision that glyphosate is ‘not likely’ to be carcinogenic to humans. EPA Already Planned Roundup Review The EPA, now under the Biden Administration, has previously indicated it already planned to conduct a new review of glyphosate and Roundup, and has asked the Supreme Court not to intercede in the case. A review that finds glyphosate to be a cancer-causing agent and threat to the environment could result in new restrictions, or even Roundup recalls, depending on the severity of the findings. Following a string of massive losses in cases that went to trial in 2018 and 2019, Bayer has engaged in efforts to settle the Roundup litigation, and indicated last year that it would pay more than $11.6 billion to resolve pending claims. However, finalization of the settlements has been slow, with many plaintiffs rejecting their individual offers and new claims continuing to be filed by individuals diagnosed with cancer following prior use of the weed killer. To limit its future liability over Roundup, Bayer recently announced plans to remove the active ingredient glyphosate from Roundup weed killers sold to U.S. residential customers by 2023. The products would still be sold under the Roundup label, but would use a different active ingredient, which has not been linked to a risk of non-Hodgkin’s lymphoma. However, glyphosate would still be used in products sold to agricultural businesses and farmers, and in product sold in other parts of the world, Bayer officials said.
Source: 
https://www.aboutlawsuits.com/epa-glyphosate-reassessment-ordered/

1 Comment

Supreme Court Rebuffs Roundup Appeal, Leaving $25M Verdict Intact

6/22/2022

0 Comments

 


 The U.S. Supreme Court has declined to hear Bayer AG's appeal of a lower court verdict over its Roundup weedkiller, leaving intact a $25 million judgment for a man who claimed the product gave him cancer. The German conglomerate, which inherited thousands of liability claims over Roundup when it acquired the Monsanto Co. in 2018, has set aside more than $4.5 billion to litigate the 30,000 or so remaining cases. Bayer, which paused settlement talks in those cases as it awaited the Supreme Court decision, is now likely to seek to quickly resolve those claims. The company had asked the high court to overturn the verdict in a lawsuit filed by California resident Edwin Hardeman, who alleged that Roundup should have included warnings that glyphosate, the herbicide's active ingredient, is a possible human carcinogen.
Joe Miller, Financial Times 6/21/2022

0 Comments

Bayer to pull glyphosate products, including Roundup, from US home and garden market

4/21/2022

0 Comments

 
https://www.nationofchange.org/2021/07/31/bayer-to-pull-glyphosate-products-including-roundup-from-us-home-and-garden-market/

Bayer's decision comes in response to the many lawsuits related to glyphosate that it inherited when it acquired Monsanto in 2018.

​
Bayer will no longer sell glyphosate-containing products to U.S. home gardeners, the company announced on Thursday.
The move comes as the company currently faces around 30,000 legal claims from customers who believe use of these products — including the flagship Roundup — caused them to develop cancer, as AgWeb reported.
“Bayer’s decision to end U.S. residential sale of Roundup is a historic victory for public health and the environment,” Center for Food Safety executive director Andrew Kimbrell said in a statement. “As agricultural, large-scale use of this toxic pesticide continues, our farmworkers remain at risk. It’s time for EPA to act and ban glyphosate for all uses.”
Glyphosate is a controversial ingredient because it has been linked to the development of non-Hodgkin lymphoma, as Cure noted. The World Health Organization’s International Agency for Research on Cancer declared that it was “probably carcinogenic to humans,” in 2015. While the U.S. Environmental Protection Agency (EPA) under former President Donald Trump ruled that the chemical did not pose any risk to human health, the Biden Administration later admitted that the review was flawed and needed to be redone, as Common Dreams reported. Still, it refused to take it off the market in the meantime.
Bayer’s decision comes in response to the many lawsuits related to glyphosate that it inherited when it acquired Monsanto in 2018. Juries sided with the plaintiffs in three highly-watched trials before Bayer settled around 95,000 cases in 2020 to the tune of $10 billion. That settlement, which was one of the largest in U.S. history, allowed Bayer to continue to sell Roundup without any warnings. However, the company still faces further litigation, and said it decided to pull the product from residential use in order to prevent more. More than 90 percent of recent claims come from the residential home and garden market, AgWeb reported.
“This move is being made exclusively to manage litigation risk and not because of any safety concerns,” the company said when it announced its decision.
The products will be replaced with different active ingredients beginning in 2023, following reviews by the EPA and state regulatory bodies. January 2023 was the earliest the change could reasonably be implemented, Bayer Crop Science Division president Liam Condon told AgWeb.
“This is from a regulatory and logistical point of view (of what’s) possible,” Condon said during a conference call with investors, as AgWeb reported.

0 Comments
<<Previous

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    October 2024
    June 2024
    January 2024
    December 2023
    June 2022
    April 2022
    July 2021
    April 2021
    December 2020
    November 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    February 2020
    November 2019

    Categories

    All

    RSS Feed

In partnership with: 

PHILADELPHIA
One Art Community Center
bioPhilly

City Parks Association
​District 1199c Training Fund
​Friends of Fernhill Park
Friends of Manatawna Farm

Friends of Vernon Park
​Northwest Philly Climate Action Network

​Our City, Our Schools Coalition
​PhilaPOSH

​Soil Generation
Temple Environmental Law Society
Toxic Free Philly Drexel University
Weaver's Way Co-op

STATE/REGIONAL
The Black Institute
Clean Air Council
​
Clean Water Action
​Delaware Riverkeeper Network

PennEnvironment
PennFuture
PennPIRG
NATIONAL
​Beyond Pesticides
​Humane Society of the United States
​Non-Toxic Communities
Physicians for Social Responsibility
​Rodale Institute
Follow us on Instagram